NSF Cuts Back On Faltering Science, Technology Centers

The agency's plans to fund up to 80 facilities at universities now seem doomed by harsh criticism and funding shortages WASHINGTON -- The National Science Foundation has decided to give its controversial science and technology centers program a rest -- a move that may please longtime critics of the program but disappoint those scientists who had hoped to land centers on their own campuses. A cornerstone of the effort by former NSF director Erich Bloch to safeguard U.S. scientific eminence and

Written byJeffrey Mervis
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

A cornerstone of the effort by former NSF director Erich Bloch to safeguard U.S. scientific eminence and at the same time shore up the country's high-tech economy, the program is now limping through a delayed second round of awards. NSF of officials have no plans right now for a third round, and there is not expected to be any money for new science and technology centers (STCs) in the 1992 budget being proposed this week by President Bush. In fact, the centers, once one of the most popular programs of the foundation, are now, according to foundation spokesman Alan Levitt, "a matter of mostly local interest."

Bloch introduced the concept of science and technology centers in January ( 1987 as a network of up to 80 university-based, interdisciplinary centers that would unleash the creative talents of thousands of scientists. Although NSF was to provide the bulk of the funding, states ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies